CA
CRDF icon

Clearstead Advisors’s Cardiff Oncology CRDF Stock Holding History

Clearstead Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13K Hold
700
– – ﹤0.01% 2020
2025
Q4 		$1.97K Hold
700
– – ﹤0.01% 2148
2025
Q3 		$1.44K Hold
700
– – ﹤0.01% 2549
2025
Q2 		$2.21K Hold
700
– – ﹤0.01% 2303
2025
Q1 		$2.2K Hold
700
– – ﹤0.01% 1885
2024
Q4 		$3.04K Hold
700
– – ﹤0.01% 1795
2024
Q3 		$1.87K Hold
700
– – ﹤0.01% 1849
2024
Q2 		$1.55K Buy
+700
New +$2.64K ﹤0.01% 1846

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Clearstead Advisors's CRDF Position: Q1 2026 in Review

Clearstead Advisors held its Cardiff Oncology (CRDF) position steady in Q1 2026 at 700 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2020.

Clearstead Advisors first reported a position in CRDF in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.04K in Q4 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Clearstead Advisors held 700 shares of Cardiff Oncology worth $1.13K as of Q1 2026.
  • Clearstead Advisors left its Cardiff Oncology share count unchanged in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #2020 holding.
  • Clearstead Advisors first reported a position in Cardiff Oncology in Q2 2024 and has held it in 8 quarters since.
  • Clearstead Advisors's Cardiff Oncology position peaked at $3.04K in Q4 2024.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.